Redefining Expanded Access for Patients With Multidrug-Resistant HIV

March 21, 2013

Nelson Vergel, B.S.Ch.E., M.B.A.

Nelson Vergel, B.S.Ch.E., M.B.A., is a leading HIV treatment advocate, author and founder of the Body Positive Wellness Center in Houston, Texas.

In a host of meetings on treatment access and HIV research, we have repeatedly heard the following statements about multidrug-resistant HIV (MDR-HIV) patients:

"These patients no longer exist -- they're either dead or have responded to the latest ARVs."

"Only patients who do not adhere to their HIV regimens have MDR-HIV."

"Our clinic cannot provide expanded access programs (EAPs) due to cost and staff restraints."

However, after surveying physicians around the country, we have found that although these patients are in a minority, they do exist and are anxiously waiting for access to viable regimens that could save their lives.

No one can deny that many patients can now suppress their HIV with effective antiretrovirals (ARVs) that cause fewer side effects. However, a vulnerable and often forgotten minority of people are still struggling with MDR-HIV while they anxiously wait for access to lifesaving ARVs that would finally control their viral replication. Although some of these patients may have developed resistant HIV due to lack of adherence or other issues, many of them have been strictly following their doctors' orders for years.

They're often veterans of drug development research who have accumulated HIV resistance as they repeatedly joined ARV studies or traditional EAPs of a single new drug out of desperation to control their HIV viral load. As they signed up for studies that helped companies get their drugs approved by the FDA (U.S. Food and Drug Administration), many of these patients were exposed to suboptimal HIV regimens (namely, functional monotherapy or the addition of a single new active ARV to a failing HIV regimen). It is time to create a new paradigm to break the vicious cycle of single-drug access that has failed these patients.

More Information: GMHC Treatment Issues, December 2012.

Get email notifications every time HIV Care Today is updated.

Copyright © 2011-2016 Remedy Health Media, LLC. All rights reserved.


Reader Comments:

Comment by: jerry jerry (hawaii) Tue., Apr. 9, 2013 at 1:34 am UTC
great article...very informative
Reply to this comment

Comment by: harleymc (Sydney, Aus) Fri., Mar. 22, 2013 at 11:38 pm UTC
Thanks for this article Nelson.
I'm a long-term user of ARVs. For the time being I currently have great control of my viral load, but this has not always been the case.

At no time since I started on medications circa 1990 have I ever had a drug regime with three new components. I have a strain of HIV resistant to multiple drugs. Yet after one of my regimes failed after several years my then doctor stated as a 'fact' I had not been adherent, without asking what my pill popping was like. I changed doctors that day.

Shutting down the voices of people who have been failed by a drug regime means that the medical profession will never learn from these failures.
Reply to this comment
Replies to this comment:
Comment by: will (florida) Mon., Apr. 22, 2013 at 10:24 pm UTC
Good comment! and not all HIV+ people are gay white men. Dr's who label their patients, have closed minds and need to seek a more suitable profession, like maybe a door stop.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.